Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors from the Natural Origin: A Recent Perspective

E-ISSN： 1875-5992|15|8|988-1011

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.15, Iss.8, 2015-01, pp. : 988-1011

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biological Characteristics and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Efficacy of EGFR Mutation and its Subtypes in Lung Adenocarcinoma

By Lu Rong-li Hu Cheng-Ping Yang Hua-ping Li Yuan-yuan Gu Qi-hua Wu Lielin

Pathology & Oncology Research, Vol. 20, Iss. 2, 2014-04 ,pp. : 445-451

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

By Rae James M.

Breast Cancer Research and Treatment, Vol. 83, Iss. 2, 2004-01 ,pp. : 99-107

Springer Publishing Company

Access to resources Recommend Favorite

Patients with peritoneal mesothelioma lack epidermal growth factor receptor tyrosine kinase mutations that would make them sensitive to tyrosine kinase inhibitors

Oncology Reports, Vol. 27, Iss. 6, 2012-01 ,pp. : 1794-1800

Spandidos Publications

Access to resources Recommend Favorite

Molecular mechanisms of lungspecific toxicity induced by epidermal growth factor receptor tyrosine kinase inhibitors (Review)

By Sakao Seiichiro Tatsumi Koichiro

Oncology Letters, Vol. 4, Iss. 5, 2012-11 ,pp. : 865-867

Spandidos Publications

Access to resources Recommend Favorite

Role of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of esophageal carcinoma and the suggested mechanisms of action (Review)

By Xu Yaping Sheng Liming Mao Weimin

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 19-24

Spandidos Publications

Access to resources Recommend Favorite